Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-14,480
Closed -$792K 3320
2022
Q1
$792K Buy
+14,480
New +$786K ﹤0.01% 2106
2019
Q3
Sell
-8,000
Closed -$400K 3095
2019
Q2
$400K Buy
+8,000
New +$401K ﹤0.01% 2174
2015
Q3
Sell
-4,036
Closed -$210K 2027
2015
Q2
$210K Buy
+4,036
New +$227K ﹤0.01% 1806

Other funds holding GSK

HSBC Holdings's GSK Position: Q1 2026 in Review

HSBC Holdings increased its GSK (GSK) stake by 29% in Q1 2026, buying an estimated $88.1K and bringing the position to 7,301 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #2319.

HSBC Holdings first reported a position in GSK in Q2 2013 and has held it in 50 quarters since. The position peaked at $162M in Q1 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • HSBC Holdings held 7,301 shares of GSK worth $400K as of Q1 2026.
  • HSBC Holdings bought 1,626 GSK shares in Q1 2026, an estimated $88.1K.
  • GSK made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2319 holding.
  • HSBC Holdings first reported a position in GSK in Q2 2013 and has held it in 50 quarters since.
  • HSBC Holdings's GSK position peaked at $162M in Q1 2024.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.